Mawer Investment Management
BIOA

Mawer Investment Management’s BioAmber Inc. BIOA Stock Holding History

Mawer Investment Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,000
Closed -$5K – 128
2017
Q3 		$5K Buy
+10,000
New +$11.9K ﹤0.01% 121

Other funds holding BIOA

NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Mawer Investment Management's BIOA Position: Q4 2017 in Review

Mawer Investment Management sold out of BioAmber Inc. (BIOA) in Q4 2017, closing a stake of 10,000 shares — an estimated $5K sold.

Mawer Investment Management first reported a position in BIOA in Q3 2017 and held it in 1 quarter. The position peaked at $5K in Q3 2017. 26 funds tracked by Wall St. Rank hold BIOA as of Q4 2017.

  • Mawer Investment Management reported no remaining BioAmber Inc. position as of Q4 2017 after selling out during the quarter.
  • Mawer Investment Management sold 10,000 BioAmber Inc. shares in Q4 2017, an estimated $5K.
  • Mawer Investment Management first reported a position in BioAmber Inc. in Q3 2017 and held it in 1 quarter.
  • Mawer Investment Management's BioAmber Inc. position peaked at $5K in Q3 2017.
  • 26 funds tracked by Wall St. Rank held BioAmber Inc. as of Q4 2017.

Based on Mawer Investment Management's 13F filing for Q4 2017, filed 9 Feb 2018.